CBD Legal or Not: How State and Federal Laws Govern the Manufacture, Marketing & Distribution of CBD Products


Date: August 16, 2018

Time: 2:00pm-3:30pm ET; 11am-12:30pm PT

Accreditation: CLE eligible for 1 hour

Don’t Forget the Final Step!
Once your payment is complete, you will get a link to provide your name and email address once more! If you miss it, click the icon below and take care of business!

Just click below to sign up! Do it by Aug. 3 and save $50!


Here is just some of what you’ll learn during this in-depth 90-minute conference:

How to interpret current state and federal laws governing the use and sale of products containing CBD.

The key questions to ask that will help determine if your CBD comes from a legal source—and what to do if it doesn’t.

How to find out which part of the plant your CBD is created from—and how what you learn could affect the legal status of your product.

What FDA approval of the first CBD drug, Epidiolex, means for the industry.

Marketing: The claims you can (and shouldn’t) make about your CBD products.

What the FDA has to say about marketing CBD as a supplement.

Is trademark protection possible under current law for CBD products—and if it is, how do you get it?

The prerequisites for legally selling CBD products across state lines or in stores that aren’t licensed to sell marijuana.


Daniel Shortt is an attorney with Harris Bricken and works extensively with entrepreneurs in the cannabis industry. He is an authority on legal issues relating to CBD and hemp laws and has spoken on these topics at events across the country and overseas. Mr. Shortt helps clients with corporate formation, transactional, licensing, regulatory, and litigation needs. He writes for the award-winning Canna Law Blog and speaks to media outlets about his perspective on legal issues in marijuana and hemp. Mr. Shortt graduated from the University of Washington School of Law where he worked extensively with the Washington State Liquor and Cannabis Board to fund and establish the Cannabis Law and Policy Project (CLPP). He then served as the editor of the CLPP blog and as a Hazelton Fellow researching cannabis law.

Alison Malsbury is an attorney with Harris Bricken. She focuses her practice on corporate and intellectual property transactions, working primarily with cannabis, tech, and entertainment clients. Ms. Malsbury has assisted clients with contracts, company formation, intellectual property protection, and regulatory compliance, and has worked with creative entrepreneurs at all stages of business development. She has a growing practice representing celebrities on cannabis endorsement deals and helping cosmetic and skin care companies navigate the complex CBD laws. Before joining Harris Bricken, Ms. Malsbury worked with the in-house legal team of one of the largest software companies in the world on its trademark and technology licensing issues. Ms. Malsbury graduated cum laude from Santa Clara University School of Law where she was the technical editor for the Santa Clara Journal of International Law.